Carolin Heller

Heidelberg University — Germany

Medicine · Health Sciences

30h-index2.8kcitations78works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyotrophic Lateral Sclerosis Research(40), Alzheimer's disease research and treatments(36), Dementia and Cognitive Impairment Research(26), Parkinson's Disease Mechanisms and Treatments(10), Prion Diseases and Protein Misfolding(9)

Publications76 total

Use of DOAC Dipstick point-of-care testing in patients with acute stroke and transient ischemic attack
Hämostaseologie·2025
Functional connectivity associations with markers of disease progression in <i>GRN</i> mutation carriers
Alzheimer s & Dementia·2024Open Access
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors
Alzheimer s Research & Therapy·2024· 14 citedOpen Access
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study
Journal of Neurology Neurosurgery & Psychiatry·2024· 6 citedOpen Access
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia
Alzheimer s Research & Therapy·2024· 13 citedOpen Access
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study
Brain Communications·2024· 11 citedOpen Access
Using GENFI participant engagement to inform observational research and clinical trials
Alzheimer s & Dementia·2023· 2 citedOpen Access
Targeted proteomic search reveals new actors in the synaptic and lysosomal dysfunction in genetic FTD, a GENFI study.
Alzheimer s & Dementia·2023Open Access
Global platform trial design for tau (MAPT) mutation carriers
Alzheimer s & Dementia·2023Open Access
Altered plasma protein profiles in genetic FTD – a GENFI study
Molecular Neurodegeneration·2023· 10 citedOpen Access
microRNA‐based predictor for diagnosis of frontotemporal dementia
Neuropathology and Applied Neurobiology·2023· 12 citedOpen Access
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease
Brain·2023· 41 citedOpen Access
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study
Neurobiology of Disease·2023· 28 citedOpen Access
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort
Brain Communications·2023· 15 citedOpen Access
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia
Brain Communications·2023· 16 citedOpen Access
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers
Brain·2022· 25 citedOpen Access
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study
Journal of Neurology·2022· 2 cited
Trajectories of neurodegeneration and seed amplification biomarkers prior to disease onset in individuals at risk of prion disease
2022Open Access
<scp>CSF</scp> glial markers are elevated in a subset of patients with genetic frontotemporal dementia
Annals of Clinical and Translational Neurology·2022· 11 citedOpen Access
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Nature Medicine·2022· 128 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jonathan D. Rohrer(47), Caroline Graff(38), Daniela Galimberti(38), James B. Rowe(38), Martina Bocchetta(37), Barbara Borroni(37), Mario Masellis(37), Matthis Synofzik(37), Christopher Butler(37), Alexander Gerhard(37), Markus Otto(37), Raquel Sánchez‐Valle(36), Maria Carmela Tartaglia(36), Elizabeth Finger(36), Alexandre de Mendonça(35), Simon Ducharme(35), Rhian S. Convery(34), Rik Vandenberghe(34), Johannes Levin(33), David M. Cash(32)